Literature DB >> 17917847

We have a problem: why have ALS trials been negative?

Michael Swash.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17917847     DOI： 10.1080/17482960701649887

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN： 1471-180X


× No keyword cloud information.
  4 in total

Review 1.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

Review 2.  The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.

Authors:  Nina Squires; Miles Humberstone; Adrian Wills; Antony Arthur
Journal:  Dysphagia       Date:  2014-05-22       Impact factor: 3.438

3.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

Review 4.  Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.

Authors:  Nakul Katyal; Raghav Govindarajan
Journal:  Front Neurol       Date:  2017-09-29       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.